ClawHub

Celgene

v1.0.0

Celgene transformed from near-bankruptcy chemical firm into a top biopharma, focusing on blood cancers with blockbuster drugs like Revlimid before BMS acquis...

⭐ 0· 33·0 current·0 all-time
by@hanxueyuan

Install

OpenClaw Prompt Flow

Install with OpenClaw

Best for remote or guided setup. Copy the exact prompt, then paste it into OpenClaw for hanxueyuan/celgene.

Previewing Install & Setup.
Prompt PreviewInstall & Setup
Install the skill "Celgene" (hanxueyuan/celgene) from ClawHub.
Skill page: https://clawhub.ai/hanxueyuan/celgene
Keep the work scoped to this skill only.
After install, inspect the skill metadata and help me finish setup.
Use only the metadata you can verify from ClawHub; do not invent missing requirements.
Ask before making any broader environment changes.

Command Line

CLI Commands

Use the direct CLI path if you want to install manually and keep every step visible.

OpenClaw CLI

Bare skill slug

openclaw skills install celgene

ClawHub CLI

Package manager switcher

npx clawhub@latest install celgene
Security Scan
VirusTotalVirusTotal
Benign
View report →
OpenClawOpenClaw
Benign
high confidence
✓
Purpose & Capability
Name and description match the content of SKILL.md (a corporate/industry case study). There are no unexpected binaries, env vars, or config paths requested.
✓
Instruction Scope
SKILL.md contains only background, timeline, analysis, and usage contexts (read_when). It does not instruct the agent to read unrelated files, call external endpoints, or collect secrets.
✓
Install Mechanism
No install spec and no code files — nothing is written to disk or fetched during install. This is the lowest-risk pattern.
✓
Credentials
The skill declares no required environment variables or credentials; nothing disproportionate is requested.
✓
Persistence & Privilege
always is false and the skill is user-invocable. It does not request persistent/privileged presence or system configuration changes.
Assessment
This skill appears to be an informational/educational skill and is internally consistent with that purpose. It requests no credentials, performs no installs, and its instructions are limited to presenting company history and analysis. If you require provenance, note the skill's source/homepage are not provided (owner ID only); if that matters for trust, ask the publisher for a homepage or source repository before installing. Otherwise it is low-risk to enable for human-invoked use.

Like a lobster shell, security has layers — review code before you run it.

latestvk97chqwzeeehgw88bwq79efwyn85p9cb
33downloads
0stars
1versions
Updated 3h ago
v1.0.0
MIT-0
@hanxueyuan
latest
Download

Celgene — 医药行业最戏剧性的困境反转

概述

Celgene 的故事是生物医药行业最令人瞩目的转型案例之一：从 1980 年代濒临破产的精细化工公司，成长为年收入超过 150 亿美元的全球顶级生物制药企业，最终在 2019 年被百时美施贵宝（BMS）以约 740 亿美元收购。

历史时间线

  • 1986年 — 从 Celanese Corporation 分拆成立
  • 1990年代初 — 几乎破产，股价一度低于 $1
  • 1995年 — 发现沙利度胺（Thalomid）在多发性骨髓瘤中的疗效，命运转折
  • 2005年 — Revlimid（来那度胺）获批，后来成为全球最畅销的抗癌药物之一
  • 2010年代 — 年收入从 $30 亿增长到超过 $150 亿
  • 2019年 — BMS 以 $740 亿美元（每股 $108 + 换股）完成收购
  • 2020年 — 品牌整合入 BMS，Celgene 作为独立公司消失

商业模式

  • 血液瘤专注：Revlimid、Pomalyst、Abraxane 等核心产品聚焦多发性骨髓瘤
  • 沙利度胺衍生物平台：基于 IMiD（免疫调节药物）的分子平台，持续开发新产品
  • 自身免疫布局：拓展到银屑病、克罗恩病等自免领域
  • 早期研发 + 并购补充：大量收购早期生物技术公司补充管线

护城河分析

  • Revlimid 专利：在其专利期内（至 2022-2026 年，因和解延长），年销售超过 $100 亿
  • 沙利度胺再发现：将一种臭名昭著的致畸药物转化为救命药物，这一科学突破难以复制
  • 血液瘤专家网络：在全球血液肿瘤学界建立了深厚的 KOL 关系

关键数据

  • 收购价格：约 $740 亿（BMS, 2019）
  • 峰值年收入：超过 $150 亿
  • 旗舰产品：Revlimid（年收入峰值超过 $120 亿）
  • 员工数（被收购前）：约 9,000 人
  • 总部：新泽西州 Summit

有趣事实

  • Revlimid 是沙利度胺（Thalidomide）的衍生物 — 后者因 1950-60 年代的致丑闻被禁用，但 Celgene 的科学家发现其在癌症中的独特机制
  • 在 Revlimid 专利到期后，BMS 面临仿制药冲击，这也是收购后的最大风险

Comments

Loading comments...